Home NDC 69853-0102-1 ANDEXXA
Product NDC 69853-0102
Requested package NDC 69853-0102-1
11-digit product format 698530102
Labeler code 69853
Product ID 69853-0102_6e8a9040-9ed4-4ef6-b782-1898fce3f76e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name andexanet alfa
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Alexion Pharmaceuticals, Inc.
Application BLA125586
Marketing category BLA
Marketing start 2019-01-08
Marketing end 2024-11-30
Substance ANDEXANET ALFA
Active strength 200 mg/20mL
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ANDEXXA ANDEXANET ALFA AstraZeneca Pharmaceuticals LP 2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c 2025-05-23 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA125586
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125586 Andexxa Coagulation Factor Xa (Recombinant), Inactivated-zhzo 351(a) Disc 2026-06-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 69853-0102-1 69853010201 4 VIAL, SINGLE-USE in 1 CARTON (69853-0102-1) > 20 mL in 1 VIAL, SINGLE-USE 2019-01-08 2024-11-30 No No Current